NASDAQ:ESTAEstablishment Labs Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $14.41 +0.50 (+3.59 %) (As of 04/9/2020 03:40 PM ET) Add Compare Share Today's Range$14.12Now: $14.41▼$14.9050-Day Range$7.56MA: $16.60▼$24.8952-Week Range$7.56Now: $14.41▼$29.78Volume6,184 shsAverage Volume199,244 shsMarket Capitalization$336.19 millionP/E RatioN/ADividend YieldN/ABeta1.33 ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingEstablishment Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.00, Establishment Labs has a potential upside of 101.2% from its current price of $14.41.Amount of Analyst CoverageEstablishment Labs has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesEstablishment Labs has received 82 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEstablishment Labs has received 81 “underperform” votes. (Add your “underperform” vote.)Community SentimentEstablishment Labs has received 50.31% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Establishment Labs and other stocks. Vote “Outperform” if you believe ESTA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ESTA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.64% of the stock of Establishment Labs is held by insiders.Percentage Held by Institutions47.95% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Establishment Labs are expected to decrease by -33.79% in the coming year, from ($1.45) to ($0.96) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -7.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -7.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 7.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.40 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ESTA Previous Symbol CUSIPN/A CIKN/A Webhttp://www.establishmentlabs.com/ Phone506 2434 2400Debt Debt-to-Equity Ratio1.22 Current Ratio4.12 Quick Ratio2.89Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$89.57 million Price / Sales3.75 Cash FlowN/A Price / Cash FlowN/A Book Value$1.92 per share Price / Book7.51Profitability EPS (Most Recent Fiscal Year)($1.86) Net Income$-38,150,000.00 Net Margins-42.60% Return on Equity-76.98% Return on Assets-34.02%Miscellaneous Employees505 Outstanding Shares23,330,000Market Cap$336.19 million Next Earnings Date5/20/2020 (Estimated) OptionableNot Optionable Receive ESTA News and Ratings via Email Sign-up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:ESTA Rates by TradingView Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions How has Establishment Labs' stock been impacted by COVID-19 (Coronavirus)? Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have decreased by 4.9% and is now trading at $14.41. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Establishment Labs? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Establishment Labs. When is Establishment Labs' next earnings date? Establishment Labs is scheduled to release its next quarterly earnings announcement on Wednesday, May 20th 2020. View our earnings forecast for Establishment Labs. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc (NASDAQ:ESTA) issued its quarterly earnings results on Monday, March, 16th. The company reported ($0.27) EPS for the quarter, topping the Zacks' consensus estimate of ($0.56) by $0.29. The firm earned $24.25 million during the quarter, compared to the consensus estimate of $24 million. Establishment Labs had a negative net margin of 42.60% and a negative return on equity of 76.98%. View Establishment Labs' earnings history. What guidance has Establishment Labs issued on next quarter's earnings? Establishment Labs issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, March, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $23-25 million, compared to the consensus revenue estimate of $25.1 million. What price target have analysts set for ESTA? 3 brokers have issued 1-year price targets for Establishment Labs' stock. Their forecasts range from $23.00 to $35.00. On average, they anticipate Establishment Labs' stock price to reach $29.00 in the next year. This suggests a possible upside of 101.2% from the stock's current price. View analysts' price targets for Establishment Labs. Has Establishment Labs been receiving favorable news coverage? Headlines about ESTA stock have been trending very negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Establishment Labs earned a news impact score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutEstablishment Labs. Who are some of Establishment Labs' key competitors? Some companies that are related to Establishment Labs include Avanos Medical (AVNS), Inogen (INGN), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), Sientra (SIEN), Allied Healthcare Products (AHPI), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Precision Therapeutics (POAI) and Ocugen (OCGN). What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include Sientra (SIEN), AbbVie (ABBV), Enterprise Products Partners (EPD), Evolus (EOLS), Huntington Bancshares (HBAN), Methanex (MEOH), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and Conduent (CNDT). Who are Establishment Labs' key executives? Establishment Labs' management team includes the following people: Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 47)Mr. Salvador Santos Dada, Chief Operating Officer (Age 37)Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 36)Ms. Renee M. Gaeta, Chief Financial Officer (Age 38)Mr. Roberto De Mezerville, Chief Technology Officer (Age 39) When did Establishment Labs IPO? (ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager. What is Establishment Labs' stock symbol? Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA." How do I buy shares of Establishment Labs? Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Establishment Labs' stock price today? One share of ESTA stock can currently be purchased for approximately $14.41. How big of a company is Establishment Labs? Establishment Labs has a market capitalization of $336.19 million and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 505 workers across the globe. View additional information about Establishment Labs. What is Establishment Labs' official website? The official website for Establishment Labs is http://www.establishmentlabs.com/. How can I contact Establishment Labs? Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected] This page was last updated on 4/9/2020 by MarketBeat.com StaffFeatured Article: How are institutional investors different from individual investors?
